True Ventures related stories
All articles and analysis
Next Frontier Capital collects $22 mln for sophomore fundNext Frontier Capital has raised $22 million for its second fund. The current target is $30 million. Based in Bozeman, Montana, the venture firm backs tech companies that are in the state.
- Personal shopping service Allume snags $3 mln seed
Silicon Valley-based Allume, on-demand personal shopping service, has raised $3 million in seed funding. The investor was True Ventures.
- Deep Genomics lands $13 mln in follow-on round led by Khosla
Deep Genomics, a Toronto genetic medicine startup, has raised $13 million in follow-on financing. Khosla Ventures led the round and was joined by True Ventures, which led the company’s $5 million seed financing in 2015. Spun out of the University of Toronto in 2014, Deep Genomics is building a biologically accurate, data- and artificial intelligence-driven technology platform that supports geneticists, molecular biologists and chemists in the development of therapies.
- ProsperWorks nabs $53 mln Series C
San Francisco-based ProsperWorks, a provider of CRM solutions for G Suite, has secured $53 million in Series C funding. Promod Haque at Norwest Venture Partners led the round with participation from GV, Industry Ventures, Next World Capital, Storm Ventures and True Ventures.
Deep Genomics lands $16 mln in follow-on round led by KhoslaDeep Genomics, a Toronto genetic medicine startup, has raised about $16 million (US$13 million) in follow-on financing. U.S. venture capital firm Khosla Ventures led the round and was joined by True Ventures, which led the company's $5 million seed financing in 2015 /canada/2015/11/deep-genomics-reels-in-c5-mln/ Spun out of the University of Toronto in 2014, Deep Genomics is building a biologically accurate, data- and artificial intelligence-driven technology platform that supports geneticists, molecular biologists and chemists in the development of therapies. It will use its platform to unlock new classes of anti-sense oligonucleotide therapies and advance them for clinical evaluation. Deep Genomics is led by CEO Brendan Frey.
- Human tissue engineering startup Prellis Biologics nabs $1.8 mln seed
San Francisco-based Prellis Biologics, a human tissue engineering startup, has secured $1.8 million in seed funding. True Ventures led the round with participation from other investors that included Civilization Ventures and 415 Ventures.